Lannett , Inc. Overview
Latest ROE for Lannett , Inc.: 62.85% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow62.85%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for LCI is 62.85%. That is above the Healthcare sector average of 22.76%. Investors often review this figure alongside Lannett , Inc.'s historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, LCI currently prints 62.85% for ROE, while the sector average sits near 22.76%. That is roughly 176.1% above the sector mean. Large gaps often invite a closer look at Lannett , Inc.'s growth, margins, and balance sheet.
Return on Equity shows how effectively Lannett , Inc. converts resources into returns. At 62.85%, LCI may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting LCI's ROE (62.85%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Lannett , Inc.'s ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
